Good Manufacturing Practices Guide for Drug Products
Health Canada's GMP guidelines (GUI-0001) interpreting the GMP requirements of Part C, Division 2 of the Food and Drug Regulations. Canada is a PIC/S member, so GUI-0001 aligns closely with PIC/S and EU GMP while reflecting Canadian establishment-licensing requirements.
What this does not cover
stated in the document's own scope- Covers GMP for finished drug products; GMP for active pharmaceutical ingredients is interpreted separately in GUI-0104 (which adopts ICH Q7).
- Interprets the GMP requirements of the Regulations but does not itself grant market authorisation — that is the drug-review pathway.
- Addresses manufacturing quality, not the establishment-licence application process, which has its own guidance (GUI-0002/GUI-0080).
Always verify against the current published text before relying on it for a submission or inspection.
Overview
GUI-0001 is Health Canada’s Good Manufacturing Practices Guide for drug products — the document that explains, requirement by requirement, what Canadian GMP actually asks a manufacturer, importer, packager, labeller, tester, or distributor to do. It walks the premises, equipment, personnel, sanitation, raw-material testing, manufacturing control, quality control, stability, records, and recall obligations that a licensed operation must meet, and it is written as interpretation: each section restates a regulatory requirement and then describes the rationale and the interpretation Health Canada applies when it inspects against it.
Scope & applicability
Fabricators, packagers/labellers, testers, importers, distributors, and wholesalers of drugs for the Canadian market holding an Establishment Licence (DEL).
Legal basis & how it acquires force
GUI-0001 interprets the binding GMP requirements set out in Part C, Division 2 of the Food and Drug Regulations, made under the Food and Drugs Act. The Regulations carry the legal obligation; the guide is Health Canada’s published interpretation of them. Compliance is tied to the Drug Establishment Licence — a site must demonstrate GMP compliance to obtain and keep one — so in practice GUI-0001 is read alongside the establishment-licensing framework rather than on its own.
Document structure
| Part | Covers |
|---|---|
| Premises, equipment, personnel | Facility, equipment, and personnel requirements (C.02.004–.006) |
| Sanitation | Sanitation programmes for premises and personnel (C.02.007–.008) |
| Raw material and packaging testing | Specifications and testing before use (C.02.009–.016) |
| Manufacturing control and quality control | Written procedures, the quality control department, and finished-product testing (C.02.011–.019) |
| Records, samples, stability, recall | Documentation, retention samples, stability programmes, sterile products, and recall (C.02.020–.024) |
Quick reference · What GUI-0001 covers
The GMP requirement areas GUI-0001 interprets under Part C, Division 2 of Canada’s Food and Drug Regulations.
- Premises — design, construction and maintenance that prevent contamination and mix-ups
- Equipment — suitable design, cleaning, maintenance and qualification
- Personnel — qualifications, training and hygiene
- Sanitation — written sanitation programmes for premises and personnel
- Raw material testing — identity and specification testing before use
- Manufacturing control — approved master and completed batch production/control records
- Quality control department — independent QC unit with defined authority to release or reject
- Packaging material testing — examination of packaging/labelling against specifications
- Finished product testing — testing against specifications before release
- Records — complete records retained for the required period
- Samples — retention samples of raw materials and finished products
- Stability — data that support the assigned expiry date
Canada is a PIC/S member, so these requirements align closely with PIC/S PE 009 and EU GMP Part I, with Canadian establishment-licensing specifics.
Source: Health Canada GUI-0001 / Food and Drug Regulations, Part C, Division 2. Verify against the current text before relying on it for a submission.
Key requirements
- Hold the appropriate Establishment Licence (DEL)
- Meet Division 2 GMP requirements as interpreted by GUI-0001
- Maintain records and data integrity
Implementation tips
- Map your PIC/S-compliant system to GUI-0001 and confirm DEL coverage for each licensable activity
Revision notes
GUI-0001 is periodically revised to reflect PIC/S alignment and Food and Drug Regulations amendments.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
Canada has been a PIC/S member since 1999, so GUI-0001 is harmonised with the PIC/S GMP Guide and, through it, closely tracks EU GMP — while retaining Canadian specifics such as bilingual labelling and the establishment-licensing regime. Foreign sites supplying the Canadian market are often covered through evidence from a recognised regulator under a mutual recognition agreement rather than by a direct Health Canada inspection.
Health Canada GUI-0001: frequently asked questions
Quick answers to common questions about Health Canada GUI-0001.
What regulation does Health Canada GUI-0001 interpret?
It interprets Part C, Division 2 of the Food and Drug Regulations, made under the Food and Drugs Act. The Regulations are the binding requirement; GUI-0001 is Health Canada’s interpretation of how to meet them.
Is GUI-0001 the same as EU GMP?
It is closely aligned. Because Canada is a PIC/S member, GUI-0001 harmonises with the PIC/S GMP Guide, which mirrors EU GMP — but it keeps Canadian-specific elements such as the Drug Establishment Licence and bilingual requirements.
Does GUI-0001 cover active pharmaceutical ingredients?
No. GUI-0001 covers finished drug products. GMP for APIs is interpreted in Health Canada’s GUI-0104, which is based on ICH Q7.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.